A Fluorescent Probe for Investigating the Activation of Anticancer Platinum(IV) Prodrugs Based on the Cisplatin Scaffold

Using Fluorescent Post-Labeling To Probe the Subcellular Localization of DNA-Targeted Platinum Anticancer Agents

(2013) Song Ding et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

NanoSIMS multi-element imaging reveals internalisation and nucleolar targeting for a highly-charged polynuclear platinum compound

(2013) Louise E. Wedlock et al.   CHEMICAL COMMUNICATIONS

Targeted delivery of platinum-based anticancer complexes

(2013) Jennifer S Butler et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

Facile Preparation of Mono-, Di- and Mixed-Carboxylato Platinum(IV) Complexes for Versatile Anticancer Prodrug Design

(2012) Jenny Z. Zhang et al.   CHEMISTRY-A EUROPEAN JOURNAL

Solid-phase synthesis of oxaliplatin–TAT peptide bioconjugates

(2012) Sergey Abramkin et al.   DALTON TRANSACTIONS

Harnessing chemoselective imine ligation for tethering bioactive molecules to platinum(iv) prodrugs

(2012) Daniel Yuan Qiang Wong et al.   DALTON TRANSACTIONS

Modulation of ligand fluorescence by the Pt(II)/Pt(IV) redox couple

(2012) Justin J. Wilson et al.   INORGANICA CHIMICA ACTA

What do we know about the reduction of Pt(IV) pro-drugs?

(2012) Ezequiel Wexselblatt et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Tuning the Activity of Platinum(IV) Anticancer Complexes through Asymmetric Acylation

(2012) Chee Fei Chin et al.   JOURNAL OF MEDICINAL CHEMISTRY

Quantitative measurement of the reduction of platinum(iv) complexes using X-ray absorption near-edge spectroscopy (XANES)

(2012) Matthew D. Hall et al.   Metallomics

Synthesis and in vitro cytotoxicity of cis,cis,trans-diamminedichloridodisuccinatoplatinum(iv)–peptide bioconjugates

(2012) Luca Gaviglio et al.   Metallomics

Fluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives

(2011) Xiaoqiang Chen et al.   CHEMICAL REVIEWS

Unique Pt5 metallacycle: [PtIICl(pyrrolidinedithiocarbamate)]5

(2011) Diego Montagner et al.   DALTON TRANSACTIONS

Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin

(2011) Michael Groessl et al.   Metallomics

Rhodamine Triazole-Based Fluorescent Probe for the Detection of Pt2+

(2010) Hyemi Kim et al.   ORGANIC LETTERS

Investigations using fluorescent ligands to monitor platinum(iv) reduction and platinum(ii) reactions in cancer cells

(2009) Elizabeth J. New et al.   DALTON TRANSACTIONS

Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate

(2009) Shanta Dhar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Fluorescent method for platinum detection in buffers and serums for cancer medicine and occupational hazards

(2008) Amanda L. Garner et al.   CHEMICAL COMMUNICATIONS

Current Status and Future Prospects for Satraplatin, an Oral Platinum Analogue

(2008) H. Choy et al.   CLINICAL CANCER RESEARCH

Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles

(2008) S. Dhar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature

(2007) Sumitra Mukhopadhyay et al.   BIOCONJUGATE CHEMISTRY